[How should severe and chronic atopic dermatitis be managed in children?].
Service de Dermatologie, Hôtel-Dieu, 44093 Nantes Cedex 01. claire.bernier@chu-nantes.fr
C
C
Bernier
D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002908:Chronic Disease; D016572:Cyclosporine / Q000627:therapeutic use; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D011701:PUVA Therapy; D012720:Severity of Illness Index
D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001379:Azathioprine